Autonomous remission of T2D was associated with a more favorable cardiovascular risk profile, namely: lower circulating triglycerides, lower leptin–adiponectin ratio, better insulin homeostasis and higher HDL cholesterol levels compared to those with active T2D of the same duration. This evidence concerns the gene INS and type 2 diabetes mellitus.